; staff. Sec. 303. Prohibition against excessive price. Sec. 304. Enforcement provisions. Sec. 305. Authority. Sec. 306. Regulations. Sec. 307. Report to Federal agencies. Sec. 308. Definitions. Sec. 309. Moratorium on direct-to-consumer drug advertising. Sec. 310. Reporting on justification for drug price increases. Title IV—Outcomes and Reporting Sec. 401. Sense of Congress. Sec. 402. Evaluation of bill’s outcome. I Transitioning to and Establishing Medicare for America A Transitional public health option 101. Establishment The Secretary of Health and Human Services (in this subtitle referred to as the Secretary ) shall establish a public health plan option that is offered in the individual market through the Federal and State Exchanges under title I of the Patient Protection and Affordable Care Act to eligible individuals for plan years 2021 and 2022 in accordance with this subtitle. 102. Eligibility Subject to subsection (b), an individual is eligible to enroll in such public health plan option if the individual is otherwise eligible to purchase individual health insurance coverage through an Exchange and the individual resides in a rating area in which the Secretary makes the public health plan option available. 103. Benefits (a) In general The public health plan option shall be a qualified health plan within the meaning of section 1301(a) of the Patient Protection and Affordable Care Act ( 42 U.S.C. 18021(a) ) that— (1) meets all requirements applicable to qualified health plans under subtitle D of title I of the Patient Protection and Affordable Care Act (other than the requirement under section 1301(a)(1)(C)(ii) of such Act ( 42 U.S.C. 18021(a)(1)(C)(ii) )) and title XXVII of the Public Health Service Act; (2) provides coverage of the essential health benefits described in section 1302(b) of the Patient Protection and Affordable Care Act ( 42 U.S.C. 18022(b) )